ArticleRSC advances2026
Fabrication of a magnetic graphene oxide-supported hexagonal cobalt MOF for fast and effective removal of tetracycline in water.
Article in RSC advances, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Antibiotic contamination in aquatic environments represents a major threat to ecosystems and human health, demanding efficient remediation strategies. This work reports the synthesis of a facile and efficient magnetic graphene oxide-supported cobalt metal-organic framework (m-GO/Co-MOF) composite for efficient tetracycline (TET) removal from water. The synthesized composite was comprehensively characterized using techniques such as Transmission Electron Microscopy (TEM), Scanning Electron Microscopy-Energy Dispersive X-ray Spectroscopy (SEM-EDX), Brunauer-Emmett-Teller (BET), Fourier Transform Infrared Spectroscopy (FTIR), and X-ray Diffraction (XRD) which confirmed its structure features, morphology, and magnetic properties. Additionally, it demonstrated a high surface area of 714.94 m
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.